A team of researcher from the lab of Stanford University biochemist Peter S. Kim has developed a vaccine for COVID-19 virus that uses a shortened spike protein from SARS-CoV-2 combined with nanoparticles of ferritin. The vaccine is a single-shot vaccine and does not require a cold-chain for storage or transport. The vaccine is in early stage of development where a single Immunization has developed SARS-CoV-2 neutralizing antibodies in Mice. Researchers are working to improve and fine-tune the vaccine candidate and hopes that this technology could produce universal coronavirus vaccine.

The report has been published in ACS Central Science, 2021, 7, 1, 183–199.